================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 18, 2004
Medicis Pharmaceutical Corporation
(Exact Name of Registrant as Specified in Charter)
Delaware 0-18443 52-1574808
(State or Other (Commission (IRS Employer
Jurisdiction of File Identification No.)
Incorporation) Number)
8125 North Hayden Road
Scottsdale, Arizona 85258-2463
(Address of Principal (Zip Code)
Executive Offices)
Registrant's telephone number, including area code: (602) 808-8800
N/A
-------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
================================================================================
Item 2. Acquisition or Disposition of Assets
On May 18, 2004, Medicis Pharmaceutical Corporation (the "Company") issued
a press release announcing that it had closed its previously announced asset
purchase agreement and license agreement, and had entered into a securities
purchase agreement with BioMarin Pharmaceutical, Inc.
A copy of the Company's press release is attached hereto as Exhibit 99.1.
Item 7. Financial Statements and Exhibits
(a) Financial Statements of Business Acquired.
Not Applicable.
(b) Pro Forma Financial Information.
Not Applicable.
(c) Exhibits.
99.1 Copy of press release, dated May 18, 2004, issued by Medicis
Pharmaceutical Corporation
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDICIS PHARMACEUTICAL
CORPORATION
(Registrant)
Date: May 18, 2004 /s/ Mark A. Prygocki, Sr.
-----------------------------------
Name: Mark A. Prygocki, Sr.
Title: Executive Vice President,
Chief Financial Officer,
Corporate Secretary and
Treasurer
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------- --------------------------------------------------------------------
99.1 Copy of press release, dated May 18, 2004, issued by Medicis
Pharmaceutical Corporation